Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement relating to COVID-19

26 Mar 2020 07:00

RNS Number : 6406H
Merian Chrysalis Investment Co. Ltd
26 March 2020
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.

 

26 March 2020

 

 

Merian Chrysalis Investment Company Limited (the "Company")

Statement relating to COVID-19

 

This is an update due to the market uncertainty relating to COVID-19 (Coronavirus). The Company would like to highlight that against this difficult backdrop its strategy remains unchanged and the Company is well-positioned at this time, in particular:

 

· The Company has no leverage in place and has a strong balance sheet with approximately £65 million of cash, after allowing for the previously disclosed follow-on investment in Embark Group, which the Company expects to complete later in Q2 2020;

· Less than 5% of the portfolio operates in business sectors most directly exposed to COVID-19, such as travel and leisure;

· The top six positions in the portfolio (Transferwise, Starling Bank, Graphcore, Klarna, The Hut Group and Embark) accounting for ca. 87% of invested NAV, in aggregate continue to trade robustly versus Merian Global Investors (the "Investment Adviser") expectations, helped by the fact they are typically on-line based;

· The majority of portfolio companies are tech-enabled: typically operating on cloud based systems, these dispersed business models are well suited to remote working;

· The portfolio companies typically have no leverage, or have substantial balance sheet liquidity, and are often backed by other well-regarded investors;

· The Investment Adviser has an active management strategy, with Board rights and/ or representation in certain cases, and so is closely engaged with portfolio companies' management and their strategy;

· A number of the Company's holdings contain downside protection and / or liquidity preference structures; and

· The Investment Adviser has activated its own business contingency plans and has seen minimal impact on its ability to transact business as a result.

 

While there will inevitably be some impact on the business plans of our key positions, the Investment Adviser's current assessment is that this is likely to be relatively modest for this group of companies. All of our investee companies have introduced business continuity programmes that the Investment Adviser considers appropriate for their organisations, as well as initial mitigation strategies.

 

A number of them have also recently raised capital, including:

 

· Graphcore - January 2020 raise of $150m, leaving a cash position of $300m;

· Klarna - July 2019 raise of $460m, with a further investment in March 2020; as of December 2019 CET1 ratio was 28.1%;

· Starling Bank - February 2020 raise of £60m, following a total of £205m raised across 2019, including the CIF award;

· The Hut Group - December 2019 raise of £66m of equity, in addition to substantial amounts of balance sheet liquidity; and

· Embark Group - £84.5m raised over 2H 2019, leaving the company in a strong liquidity position.

 

In addition, Transferwise, Klarna and The Hut Group have proven profit generating capabilities.

 

Whilst it is early days in terms of the effects of COVID-19, and the full impact on trading of our investee companies is impossible to predict at this time, the Board and the Investment Adviser are closely monitoring the situation and offering support where needed, with a view to ensuring that any impact is mitigated wherever possible.

 

 

-ENDS-

 

 

For further information, please contact:

 

Merian Global Investors:

Amelie Shepherd

 

 

 

+44 (0) 20 7332 7500

 

Liberum:

Gillian Martin / Owen Matthews

 

+44 (0) 20 3100 2000

Maitland Administration (Guernsey) Limited:

Elaine Smeja

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUVAORRRUOUUR
Date   Source Headline
18th Dec 202012:18 pmRNSResults of Extraordinary General Meeting
17th Dec 20204:38 pmRNSDirector Declaration
11th Dec 20207:00 amRNSNet Asset Value(s)
27th Nov 20203:03 pmRNSDirector/PDMR Shareholding
27th Nov 20203:02 pmRNSDirector/PDMR Shareholding
25th Nov 20203:38 pmRNSProposed Change of Name
8th Oct 20204:23 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSResults of Capital Raise
6th Oct 202011:20 amRNSUpdate on Placing
1st Oct 20207:00 amRNSPortfolio Update
28th Sep 202010:07 amRNSPrimaryBid.com Offer
28th Sep 202010:00 amRNSProposed Placing of Equity
22nd Sep 20205:05 pmRNSHolding(s) in Company
16th Sep 20209:11 amRNSPortfolio Update
15th Sep 20208:58 amRNSPortfolio Update
11th Sep 20207:00 amRNSPortfolio Update
10th Sep 20204:41 pmRNSSecond Price Monitoring Extn
10th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Sep 202012:07 pmRNSSecond Price Monitoring Extn
10th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Sep 202012:07 pmRNSSecond Price Monitoring Extn
8th Sep 202012:02 pmRNSPrice Monitoring Extension
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSNet Asset Value(s)
29th Jul 20207:00 amRNSPortfolio Update
20th Jul 20207:00 amRNSPortfolio Update
6th Jul 202012:31 pmRNSHolding(s) in Company
6th Jul 202012:28 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSInterim Accounts to 31 March 2020
23rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jun 202012:02 pmRNSPrice Monitoring Extension
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSQuarterly NAV and COVID-19 Portfolio Update
13th May 202012:07 pmRNSSecond Price Monitoring Extn
13th May 202012:02 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPortfolio Update
7th May 20204:40 pmRNSSecond Price Monitoring Extn
7th May 20204:35 pmRNSPrice Monitoring Extension
6th May 202012:08 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSStatement relating to COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.